(VIANEWS) – TrueBlue Shares Plunge 24.67% Amid on-going Losses
TrueBlue (NYSE: TBI) shares experienced a dramatic 24.67% drop, closing at EUR10.29 at 14:01 EST on Tuesday – ending their four-session losing streak and helping bring in positive gains with the NYSE index increasing by 0.13% to EUR14,965.77.
TrueBlue has experienced a steady downward trajectory, trading 38.77% below its 52-week high of EUR22.31. Investors may have responded negatively to recent financial news from TrueBlue which may be behind its declining share value.
About TrueBlue
TrueBlue, Inc. is a premier provider of workforce solutions across North America, Europe, Australia and Puerto Rico, offering services across three segments: PeopleReady, PeopleManagement and PeopleScout. PeopleReady offers staffing services across various industries while PeopleManagement offers on-site industrial staffing as well as commercial driver placement. Finally, PeopleScout provides recruitment process outsourcing, talent advisory services and managed service solutions with real-time insights using technology and AI for recruitment process outsourcing and talent advisory solutions. Established as Labor Ready Inc in 1985 and headquartered out of Tacoma Washington since then
Yearly Analysis
Based on this information, here is a short investment outlook for TrueBlue stock:
TrueBlue’s stock price has dropped dramatically from its 52-week high of EUR13.52, suggesting it has been oversold and investors may be searching for signs of recovery.
TrueBlue is expecting its sales growth for this year to drop 14.4%, which could indicate it is experiencing significant challenges that threaten its profitability and long-term growth prospects. Meanwhile, their projected sales growth for next year stands at 4.4% – relatively modest numbers indeed!
On a positive note, TrueBlue’s EBITDA stands at 61.31, suggesting it has positive cash flow generation and has a relatively healthy financial position.
Overall, investors should approach TrueBlue stock with extreme caution and conduct additional research to assess its fundamentals and growth prospects. While the current stock price may offer an attractive entry point, investors should carefully consider any risks associated with TrueBlue’s sales growth prospects before making their decisions.
Technical Analysis
TrueBlue Stock Revels Below Moving Averages and Experiences High Trading Volume. TrueBlue’s current stock price of EUR10.46 falls significantly below both its 50-day moving average of EUR14.71 and 200-day moving average of EUR16.86. This indicates a bearish trend in both the short- and long-term for the stock. Today’s trading volume of 909,115 represents an astounding 289.96% increase over its average of 233,128, reflecting increased interest and activity surrounding this stock. Volatility has been relatively low over the past quarter with an average daily range of only 1.72%; however, stochastic oscillator indications that the stock may currently be overbought (>=80), suggesting a potential correction or pullback could occur within weeks or months; investors should keep an eye on these indicators to monitor its performance closely.
Quarter Analysis
Based on the available data, TrueBlue appears to be experiencing financial difficulty; their sales growth for both current and subsequent quarters was negative, as was year-on-year revenue growth.
Investors should exercise extreme caution when considering TrueBlue as its growth estimates for both this quarter and next are negative, showing a decrease of 69.3% this time and 53.5% in the following.
Negative growth signals a decrease in financial performance and should be of concern to investors seeking long-term growth opportunities. They should explore other investments with more positive prospects given today’s uncertain economy.
Equity Analysis
TrueBlue currently boasts a trailing twelve month earnings per share (EPS) figure of EUR0.47, signifying that over the past year they have generated that amount in earnings per share (EPS).
The company’s trailing twelve month price to earnings ratio stands at 21.89, indicating that investors are willing to pay EUR21.89 for every euro of annual earnings generated. While an elevated PE ratio may indicate overvaluation of stock, it also can signal optimism regarding its future potential.
TrueBlue’s return on equity (ROE) for the twelve trailing months stands at 3.51%. This indicates the company generated a profit of this amount on shareholder’s equity over this timeframe. Although TrueBlue’s ROE may seem low compared to similar businesses, investors should carefully consider other aspects such as growth potential, competitive position and industry trends before making an investment decision.
Conclusion Investors should carefully evaluate TrueBlue as an investment opportunity by taking into account its profitability, valuation, growth prospects and return on equity metrics. Furthermore, it may be beneficial to compare TrueBlue’s financial metrics against those of its competitors for an idea of its relative performance within its industry.
More news about TrueBlue (TBI).
